Moxetumomab pasudotox

From WikiMD.org
Jump to navigation Jump to search
Moxetumomab pasudotox
TermMoxetumomab pasudotox
Short definitionMoxetumomab pasudotox - (pronounced) (MOK-see-TOO-moh-mab pah-SOO-doh-tox) A drug used to treat adults with hairy cell leukemia who have come back or not improved with at least two other systemic therapies, including treatment with a purine nucleoside analogue (a type of cancer drug). Moxetumomab Pasudotox contains a monoclonal antibody that attaches to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of leukemia cells. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Moxetumomab pasudotox - (pronounced) (MOK-see-TOO-moh-mab pah-SOO-doh-tox) A drug used to treat adults with hairy cell leukemia who have come back or not improved with at least two other systemic therapies, including treatment with a purine nucleoside analogue (a type of cancer drug). Moxetumomab Pasudotox contains a monoclonal antibody that attaches to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of leukemia cells. It also contains a bacterial toxin called PE38 that can help kill cancer cells. Moxetumomab pasudotox is a type of immunotoxin. Also called anti-CD22 immunotoxin CAT-8015, CAT-8015 and Lumoxiti

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski